Overcoming the Underutilisation of Peritoneal Dialysis

Jernej Pajek, Jernej Pajek

Abstract

Peritoneal dialysis is troubled with declining utilisation as a form of renal replacement therapy in developed countries. We review key aspects of therapy evidenced to have a potential to increase its utilisation. The best evidence to repopulate PD programmes is provided for the positive impact of timely referral and systematic and motivational predialysis education: average odds ratio for instituting peritoneal dialysis versus haemodialysis was 2.6 across several retrospective studies on the impact of predialysis education. Utilisation of PD for unplanned acute dialysis starts facilitated by implantation of peritoneal catheters by interventional nephrologists may diminish the vast predominance of haemodialysis done by central venous catheters for unplanned dialysis start. Assisted peritoneal dialysis can improve accessibility of home based dialysis to elderly, frail, and dependant patients, whose quality of life on replacement therapy may benefit most from dialysis performed at home. Peritoneal dialysis providers should perform close monitoring, preventing measures, and timely prophylactic therapy in patients judged to be prone to EPS development. Each peritoneal dialysis programme should regularly monitor, report, and act on key quality indicators to manifest its ability of constant quality improvement and elevate the confidence of interested patients and financing bodies in the programme.

Figures

Figure 1
Figure 1
Dropping number of PD patients in the example of Slovenia's national PD cohort for the time period from 2004 to 2014.
Figure 2
Figure 2
Summary of key steps in overcoming the underutilisation of peritoneal dialysis programmes.

References

    1. Jain A. K., Blake P., Cordy P., Garg A. X. Global trends in rates of peritoneal dialysis. Journal of the American Society of Nephrology. 2012;23(3):533–544. doi: 10.1681/ASN.2011060607.
    1. van Walraven C., Manuel D. G., Knoll G. Survival trends in ESRD patients compared with the general population in the United States. American Journal of Kidney Diseases. 2014;63(3):491–499. doi: 10.1053/j.ajkd.2013.09.011.
    1. Blake P. Proliferation of hemodialysis units and declining peritoneal dialysis use: an international trend. American Journal of Kidney Diseases. 2009;54(2):194–196. doi: 10.1053/j.ajkd.2009.04.003.
    1. Hörl W. H., de Alvaro F., Williams P. F. Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: access to ESRD treatments. Nephrology Dialysis Transplantation. 1999;14(supplement 6):10–15.
    1. Nissenson A. R., Prichard S. S., Cheng I. K. P., et al. Non-medical factors that impact on ESRD modality selection. Kidney International. 1993;40:S120–S127.
    1. Mehrotra R., Blake P., Berman N., Nolph K. D. An analysis of dialysis training in the United States and Canada. American Journal of Kidney Diseases. 2002;40(1):152–160. doi: 10.1053/ajkd.2002.33924.
    1. Chaudhary K., Sangha H., Khanna R. Peritoneal dialysis first: rationale. Clinical Journal of the American Society of Nephrology. 2011;6(2):447–456. doi: 10.2215/cjn.07920910.
    1. Wang A. Y.-M., Lai K.-N. The importance of residual renal function in dialysis patients. Kidney International. 2006;69(10):1726–1732. doi: 10.1038/sj.ki.5000382.
    1. Oliver M. J., Verrelli M., Zacharias J. M., et al. Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrology Dialysis Transplantation. 2012;27(2):810–816. doi: 10.1093/ndt/gfr289.
    1. Quinn R. R., Ravani P., Zhang X., et al. Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis. Peritoneal Dialysis International. 2014;34(1):41–48. doi: 10.3747/pdi.2012.00257.
    1. Vanholder R., Heering P., Van Loo A., et al. Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis. American Journal of Kidney Diseases. 1999;33(5):934–940. doi: 10.1016/S0272-6386(99)70429-4.
    1. Molnar M. Z., Mehrotra R., Duong U., et al. Dialysis modality and outcomes in kidney transplant recipients. Clinical Journal of the American Society of Nephrology. 2012;7(2):332–341. doi: 10.2215/CJN.07110711.
    1. Mehrotra R., Chiu Y.-W., Kalantar-Zadeh K., Bargman J., Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Archives of Internal Medicine. 2011;171(2):110–118. doi: 10.1001/archinternmed.2010.352.
    1. Lameire N., Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist—a European survey. Nephrology Dialysis Transplantation. 1999;14(supplement 6):16–23.
    1. Arora P., Obrador G. T., Ruthazer R., et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. Journal of the American Society of Nephrology. 1999;10(6):1281–1286.
    1. Ifudu O., Dawood M., Homel P., Friedman E. A. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. American Journal of Kidney Diseases. 1996;28(6):841–845. doi: 10.1016/S0272-6386(96)90383-2.
    1. Pérez-García R., Martín-Malo A., Fort J., et al. Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER—a multicentre, prospective, observational cohort study. Nephrology Dialysis Transplantation. 2009;24(2):578–588. doi: 10.1093/ndt/gfn464.
    1. Cass A., Cunningham J., Snelling P., Ayanian J. Z. Late referral to a nephrologist reduces access to renal transplantation. American Journal of Kidney Diseases. 2003;42(5):1043–1049. doi: 10.1016/j.ajkd.2003.07.006.
    1. Chandna S. M., Schulz J., Lawrence C., Greenwood R. N., Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. British Medical Journal. 1999;318(7178):217–223. doi: 10.1136/bmj.318.7178.217.
    1. Navaneethan S. D., Aloudat S., Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrology. 2008;9, article 3 doi: 10.1186/1471-2369-9-3.
    1. Devins G. M., Mendelssohn D. C., Barré P. E., Taub K., Binik Y. M. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. American Journal of Kidney Diseases. 2005;46(6):1088–1098. doi: 10.1053/j.ajkd.2005.08.017.
    1. Kim D. H., Kim M., Kim H., et al. Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS ONE. 2013;8(1):10. doi: 10.1371/journal.pone.0055323.e55323
    1. Lameire N., Wauters J.-P., Górriz Teruel J. L., Van Biesen W., Vanholder R. An update on the referral pattern of patients with end-stage renal disease. Kidney International, Supplement. 2002;61(80):27–34. doi: 10.1046/j.1523-1755.61.s80.6.x.
    1. Mendelssohn D. C., Malmberg C., Hamandi B. An integrated review of ‘unplanned’ dialysis initiation: reframing the terminology to ‘suboptimal’ initiation. BMC Nephrology. 2009;10, article 22 doi: 10.1186/1471-2369-10-22.
    1. Baer G., Lameire N., Van Biesen W. Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions. NDT Plus. 2010;3(1):17–27. doi: 10.1093/ndtplus/sfp050.
    1. Pisoni R. L., Arrington C. J., Albert J. M., et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. American Journal of Kidney Diseases. 2009;53(3):475–491. doi: 10.1053/j.ajkd.2008.10.043.
    1. Lobbedez T., Lecouf A., Ficheux M., Henri P., De Ligny B. H., Ryckelynck J.-P. Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience. Nephrology Dialysis Transplantation. 2008;23(10):3290–3294. doi: 10.1093/ndt/gfn213.
    1. Arramreddy R., Zheng S., Saxena A. B., Liebman S. E., Wong L. Urgent-start peritoneal dialysis: a chance for a new beginning. American Journal of Kidney Diseases. 2014;63(3):390–395. doi: 10.1053/j.ajkd.2013.09.018.
    1. Povlsen J. V., Ivarsen P. How to start the late referred ESRD patient urgently on chronic APD. Nephrology Dialysis Transplantation. 2006;21(supplement 2):ii56–ii59. doi: 10.1093/ndt/gfl192.
    1. Ranganathan D., Baer R., Fassett R. G., et al. Randomised controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimise complications (Timely PD study) BMC Nephrology. 2010;11, article 11 doi: 10.1186/1471-2369-11-11.
    1. Ng E. K., Goh B. L., Chew S. E., et al. Multicenter analysis on the impact of nephrologist-initiated catheter insertion program on peritoneal dialysis penetration. Seminars in Dialysis. 2012;25(5):569–573. doi: 10.1111/j.1525-139x.2012.01051.x.
    1. Goh B. L., Ganeshadeva Y. M., Chew S. E., Dalimi M. S. Does peritoneal dialysis catheter insertion by interventional nephrologists enhance peritoneal dialysis penetration? Seminars in Dialysis. 2008;21(6):561–566. doi: 10.1111/j.1525-139x.2008.00478.x.
    1. Asif A., Pflederer T. A., Vieira C. F., Diego J., Roth D., Agarwal A. Does catheter insertion by nephrologists improve peritoneal dialysis utilization? A multicenter analysis. Seminars in Dialysis. 2005;18(2):157–160. doi: 10.1111/j.1525-139x.2005.18204.x.
    1. Perl J., Pierratos A., Kandasamy G., et al. Peritoneal dialysis catheter implantation by nephrologists is associated with higher rates of peritoneal dialysis utilization: a population-based study. Nephrology Dialysis Transplantation. 2015;30(2):301–309. doi: 10.1093/ndt/gfu359.
    1. de Moraes T. P., Campos R. P., de Alcântara M. T., et al. Similar outcomes of catheters implanted by nephrologists and surgeons: analysis of the Brazilian peritoneal dialysis multicentric study. Seminars in Dialysis. 2012;25(5):565–568. doi: 10.1111/j.1525-139x.2012.01050.x.
    1. Crabtree J. H. Peritoneal dialysis catheter implantation: avoiding problems and optimizing outcomes. Seminars in Dialysis. 2015;28(1):12–15. doi: 10.1111/sdi.12299.
    1. Haggerty S., Roth S., Walsh D., et al. Guidelines for laparoscopic peritoneal dialysis access surgery. Surgical Endoscopy. 2014;28(11):3016–3045. doi: 10.1007/s00464-014-3851-9.
    1. Malovrh M. Vascular access creation and care should be provided by nephrologists. The Journal of Vascular Access. 2015;16(supplement 9):S20–S23. doi: 10.5301/jva.5000332.
    1. Chanouzas D., Ng K. P., Fallouh B., Baharani J. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrology Dialysis Transplantation. 2012;27(4):1542–1547. doi: 10.1093/ndt/gfr452.
    1. Lobbedez T., Moldovan R., Lecame M., Hurault de Ligny B., El Haggan W., Ryckelynck J.-P. Assisted peritoneal dialysis. Experience in a French renal department. Peritoneal Dialysis International. 2006;26(6):671–676.
    1. Oliver M. J., Quinn R. R., Richardson E. P., Kiss A. J., Lamping D. L., Manns B. J. Home care assistance and the utilization of peritoneal dialysis. Kidney International. 2007;71(7):673–678. doi: 10.1038/sj.ki.5002107.
    1. Franco M. R. G., Fernandes N., Ribeiro C. A., Qureshi A. R., divino-Filho J. C., da Glória Lima M. A Brazilian experience in assisted automated peritoneal dialysis: a reliable and effective home care approach. Peritoneal Dialysis International. 2013;33(3):252–258. doi: 10.3747/pdi.2012.00031.
    1. Oliver M. J., Garg A. X., Blake P. G., et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrology Dialysis Transplantation. 2010;25(8):2737–2744. doi: 10.1093/ndt/gfq085.
    1. Castrale C., Evans D., Verger C., et al. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF) Nephrology Dialysis Transplantation. 2010;25(1):255–262. doi: 10.1093/ndt/gfp375.
    1. Smyth A., McCann E., Redahan L., Lambert B., Mellotte G. J., Wall C. A. Peritoneal dialysis in an ageing population: a 10-year experience. International Urology and Nephrology. 2012;44(1):283–293. doi: 10.1007/s11255-011-9973-2.
    1. Dratwa M. Costs of home assistance for peritoneal dialysis: results of a European survey. Kidney International. 2008;73(108):S72–S75. doi: 10.1038/sj.ki.5002605.
    1. Brown E. A., Van Biesen W., Finkelstein F. O., et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Peritoneal Dialysis International. 2009;29(6):595–600.
    1. Garosi G., Oreopoulos D. G. No need for an ‘expiry date’ in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis. International Urology and Nephrology. 2009;41(4):903–907. doi: 10.1007/s11255-009-9661-7.
    1. Johnson D. W., Brown F. G., Clarke M., et al. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: The balANZ trial. Nephrology Dialysis Transplantation. 2012;27(12):4445–4453. doi: 10.1093/ndt/gfs314.
    1. Johnson D. W., Brown F. G., Clarke M., et al. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial. Peritoneal Dialysis International. 2012;32(5):497–506. doi: 10.3747/pdi.2012.00052.
    1. Mortier S., Faict D., Schalkwijk C. G., Lameire N. H., De Vriese A. S. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney International. 2004;66(3):1257–1265. doi: 10.1111/j.1523-1755.2004.00879.x.
    1. Kawanishi K., Honda K., Tsukada M., Oda H., Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Peritoneal Dialysis International. 2013;33(3):242–251. doi: 10.3747/pdi.2011.00270.
    1. Davies S. J., Phillips L., Naish P. F., Russell G. I. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. Journal of the American Society of Nephrology. 2001;12(5):1046–1051.
    1. Subeq Y.-M., Ke C.-Y., Lin N.-T., Lee C.-J., Chiu Y.-H., Hsu B.-G. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine. 2011;53(2):223–230. doi: 10.1016/j.cyto.2010.11.004.
    1. Vazquez-Rangel A., Soto V., Escalona M., et al. Spironolactone to prevent peritoneal fibrosis in peritoneal dialysis patients: a randomized controlled trial. American Journal of Kidney Diseases. 2014;63(6):1072–1074. doi: 10.1053/j.ajkd.2014.01.426.
    1. Trošt Rupnik A., Pajek J., Guček A., et al. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients. Therapeutic Apheresis and Dialysis. 2013;17(4):425–430. doi: 10.1111/1744-9987.12091.
    1. Garosi G., Mancianti N., Corciulo R., La Milia V., Virga G. Encapsulating peritoneal sclerosis. Journal of Nephrology. 2013;26(supplement 2):177–187.
    1. del Peso G., Bajo M. A., Gil F., et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Advances in Peritoneal Dialysis. 2003;19:32–35.
    1. Tranaeus A. No need for an ‘expiry date’ in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world. International Urology and Nephrology. 2010;42:240–241.
    1. Cornelis T., Oreopoulos D. G. Update on potential medical treatments for encapsulating peritoneal sclerosis; Human and experimental data. International Urology and Nephrology. 2011;43(1):147–156. doi: 10.1007/s11255-010-9744-5.
    1. Sampimon D. E., Korte M. R., Barreto D. L., et al. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Peritoneal Dialysis International. 2010;30(2):163–169. doi: 10.3747/pdi.2009.00022.
    1. Pajek J., Hutchison A. J., Bhutani S., et al. Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis. Peritoneal Dialysis International. 2014;34(3):289–298. doi: 10.3747/pdi.2012.00248.
    1. Kawanishi H. No need for an ‘expiry date’ in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world. International Urology and Nephrology. 2010;42(1):239–249. doi: 10.1007/s11255-010-9705-z.
    1. Yamamoto T., Nagasue K., Okuno S., Yamakawa T. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Peritoneal Dialysis International. 2010;30(3):343–352. doi: 10.3747/pdi.2008.00273.
    1. Li P. K.-T., Szeto C. C., Piraino B., et al. Peritoneal dialysis-related infections recommendations: 2010 update. Peritoneal Dialysis International. 2010;30(4):393–423. doi: 10.3747/pdi.2010.00049.
    1. Piraino B., Bernardini J., Brown E., et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Peritoneal Dialysis International. 2011;31(6):614–630. doi: 10.3747/pdi.2011.00057.
    1. Ahlmén J., Carlsson L., Schönborg C. Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Peritoneal Dialysis International. 1993;13(supplement 2):S196–S198.
    1. Prichard S. S. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Peritoneal Dialysis International. 1996;16(1):69–72.
    1. Little J., Irwin A., Marshall T., Rayner H., Smith S. Predicting a patient's choice of dialysis modality: experience in a United Kingdom renal department. American Journal of Kidney Diseases. 2001;37(5):981–986. doi: 10.1016/s0272-6386(05)80014-9.
    1. Marrón B., Martínez Ocaña J. C., Salgueira M., et al. Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Peritoneal Dialysis International. 2005;25(supplement 3):S56–S59.
    1. Ribitsch W., Haditsch B., Otto R., et al. Effects of a pre-dialysis patient education program on the relative frequencies of dialysis modalities. Peritoneal Dialysis International. 2013;33(4):367–371. doi: 10.3747/pdi.2011.00255.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir